KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Inventory Average (2018 - 2025)

Historic Inventory Average for Bionano Genomics (BNGO) over the last 8 years, with Q3 2025 value amounting to $7.8 million.

  • Bionano Genomics' Inventory Average fell 5360.08% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 5360.08%. This contributed to the annual value of $17.0 million for FY2024, which is 3540.16% down from last year.
  • Per Bionano Genomics' latest filing, its Inventory Average stood at $7.8 million for Q3 2025, which was down 5360.08% from $9.1 million recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' Inventory Average peaked at $32.8 million during Q2 2023, and registered a low of $3.2 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $16.9 million (2024), whereas its average is $17.0 million.
  • In the last 5 years, Bionano Genomics' Inventory Average soared by 36503.91% in 2022 and then crashed by 5360.08% in 2025.
  • Quarter analysis of 5 years shows Bionano Genomics' Inventory Average stood at $10.7 million in 2021, then surged by 156.02% to $27.4 million in 2022, then decreased by 10.01% to $24.7 million in 2023, then crashed by 48.41% to $12.7 million in 2024, then crashed by 38.37% to $7.8 million in 2025.
  • Its Inventory Average was $7.8 million in Q3 2025, compared to $9.1 million in Q2 2025 and $10.3 million in Q1 2025.